SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-19-003911
Filing Date
2019-03-11
Accepted
2019-03-11 16:22:38
Documents
97
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f20f2018_xtlbiopharma.htm 20-F 1678515
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULE 13A-14(A)/15D-14(A), A f20f2018ex12-1_xtlbiopharma.htm EX-12.1 11927
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13A-14(A)/15D-14(A), A f20f2018ex12-2_xtlbiopharma.htm EX-12.2 12053
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUANT TO f20f2018ex13-1_xtlbiopharma.htm EX-13.1 5224
11 GRAPHIC img_001.jpg GRAPHIC 5398
12 GRAPHIC img_002.jpg GRAPHIC 77651
  Complete submission text file 0001213900-19-003911.txt   6097219

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE xtlb-20181231.xml EX-101.INS 1120368
6 XBRL SCHEMA FILE xtlb-20181231.xsd EX-101.SCH 92619
7 XBRL CALCULATION FILE xtlb-20181231_cal.xml EX-101.CAL 45590
8 XBRL DEFINITION FILE xtlb-20181231_def.xml EX-101.DEF 142963
9 XBRL LABEL FILE xtlb-20181231_lab.xml EX-101.LAB 463651
10 XBRL PRESENTATION FILE xtlb-20181231_pre.xml EX-101.PRE 312478
Mailing Address 5 HACHAROSHET ST. RAANANA L3 4365603
Business Address XTL BIOPHARMACEUTICALS LTD C/O ALSTON & BIRD LLP, 90 PARK AVENUE NEW YORK NY 10016 972 9 955 7080
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3
Type: 20-F | Act: 34 | File No.: 001-36000 | Film No.: 19672591
SIC: 2834 Pharmaceutical Preparations